APPLICATIONS PUBLISHED 26 FEBRUARY 2003

Published: 1-Aug-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Self-emulsifying active substance formulation and use of this formulation
    BASF 1284716*

  • Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation base
    BASF 1284717*

  • Occlusive transdermal therapeutic system with a non-occlusive backing layer
    LTS Lohmann Therapie-Systeme 1284718*

  • Use of a calcium channel blocker for treating renal disorders
    Pfizer 1284719*

  • Method of treating hepatitis delta virus infection
    Georgetown University; Cornell Research Foundation; University of Georgia Research Foundation 1284720*

  • Compsns and methods of use against acne-induced inflammation and dermal matrix-degrading enzymes
    The Regents of the University of Michigan 1284721*

  • Compsns containing a benzamide disulphide derivative for treating allergic diseases
    Alcon 1284722*

  • Compsns and therapies for hyperlipidaemia-associated disorders
    Borody, Thomas Julius 1284723*

  • Method of preparing alkylated salicylamides via a dicarboxylic intermediate
    Emisphere Technologies 1284724*

  • Medicament for the treatment of diseases caused by parasitic protozoa
    Hofer, Anders; Thelander, Lars 1284725*

  • Method of chlamydia prophylaxis
    Children's Hospital Medical Centre 1284726*

  • Intracoporeal medicaments for photodynamic treatment of disease
    Photogen 1284727*

  • Pharmaceuticals for treating obesity
    Merck 1284728*

  • A(beta)42 lowering agents
    Mayo Foundation for Medical Education and Research 1284729*

  • Aralkyl ester soft drugs
    The University of Toledo 1284730*

  • Use of compounds having combined dopamine D2, 5-HT1A and alpha adrenoreceptor agonist action for treating CNS disorders
    Solvay Pharmaceuticals 1284731*

  • Method for treating functional dyspepsia using alosetron
    Glaxo Group 1284732*

  • Novel processes for preparing torsemide intermediate
    Teva Pharmaceutical Industry 1284733*

  • Protein kinase inhibitors
    Peptor; Yissum Research Development of the Hebrew University of Jerusalem 1284734*

  • Apomorphine derivatives and methods for their use
    Tap Holdings 1284735*

  • Opioid antagonist compsns and dosage forms
    Pain Therapeutics; Albert Einstein College of Medicine of Yeshiva University 1284736*

  • Water soluble prodrugs of azole compounds
    Bristol-Myers Squibb 1284737*

  • (+)-naxolone and epinephrine combination therapy
    Sure Medical 1284738*

  • Compsn and method and method for intervening neuronal death using sulfasalazine
    Neurotech 1284739*

  • Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds
    Corixa 1284740*

  • 3'- or 2'-hyroxymethyl substituted nucleosides derivatives for treatment of hepatitis virus infections
    Pharmaset 1284741*

  • Biological joint lubricant compsn and method of applying
    Chemson University 1284742*

  • Preparation of a pathogen inactivated solution of red blood cells having reduced mutogenicity
    Cerus Corp 1284743*

  • Antimigraine combination comprising sapindus and emblica extracts
    Lupin Laboratories 1284744*

  • Use of Piper methysticum or Piper wichmannii extracts for treating alcohol dependence
    Pernod-Ricard 1284745*

  • A method of treatment and prophylaxis
    Amrad Operations 1284748*

  • Compsns and methods for achieving immune suppression
    Beth Israel Deaconess Medical Centre 1284747*

  • Treatment of damaged connective tissue
    GroPep 1284748*

  • Use of hyaluronidase for preventing or treating cardio vascular diseases
    Burgard, Gunther; Cullmann, Heinz Dieter 1284749*

  • Pharmaceutical compsn
    Ribeiro Santana; Cristiano Alberto 1284750*

  • Compsns and methods for induction of active autoimmunity
    National Tsing Hua University 1284751*

  • Bispecific molecules and uses thereof
    Elusys Therapeutics 1284752*

  • Combination of growth hormone secretagogues and antidepressants
    Pfizer Products 1285753*

  • Gel-like pharmaceutical compsn for subcutaneous administration comprising bisphosphonic acids or their salts
    F Hoffmann-La Roche 1284754*

  • You may also like